Starpharma (OTCOX: SPRHY) Subsidiary May Aid in Early Detection
Already working on a microbicide that could help prevent the spread of HIV and genital herpes, Starpharma recently announced that through its subsidiary, Dendritic Nanotechnologies Inc., it may also be able to help scientists uncover previously undetectable disease markers. The U.S. - based subsidiary says its Priostar dendrimer technology can increase and enhance products already in use in the fluorescent reagents market. What's a dendrimer? In its most simple explanation, dendrimers are repeatedly branched molecules. Using fluorescent reagents in various ways, laboratories study diseases at their most basic parts - the markers found genetically. Many of these markers are undetectable…